Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Kushi Kullar who wrote (952)	3/27/1999 9:41:00 PM
From: LLCF	Read Replies (1) \| Respond to of 3202

< no credible IR or PR. Need that plus good offerings to drive stock. > IMO PR is only good for traders, or companies that want to sell more stock. Doesn't do any good. Example is ENZN... people over on that thread whined for 2 years about the other companies with less promising science who's stocks were much more richly priced , etc. etc.... well when ENZN went into phase 3 with all this stuff PUFF... the stock went up almost 10 fold. No PR needed. Believe me, if INCY keeps the contracts coming, and profits roll in a couple years from now the stock will go up. If not, down she goes... same with HGSI. DAK